|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.42 HKD | +3.50% |
|
+12.70% | -37.46% |
Genscript Biotech Corporation reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was USD 304.68 million compared to USD 229.57 million a year ago. Net loss was USD 131.2 million compared to USD 91.12 million a year ago.
Basic loss per share from continuing operations was USD 0.0628 compared to USD 0.0461 a year ago. Diluted loss per share from continuing operations was USD 0.0628 compared to USD 0.0461 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -37.46% | 3.26B | |
| +21.99% | 47.9B | |
| +46.56% | 41.42B | |
| -2.47% | 40.7B | |
| -6.20% | 28.92B | |
| +10.84% | 25.55B | |
| -21.28% | 19.27B | |
| -1.79% | 12.15B | |
| +30.92% | 12.14B | |
| -0.45% | 11.99B |
GENSCRIPT BIOTECH CORPORATION 